and everyone. good Thanks, Jim morning,
of one be us worth consumer Turning contained proprietary attempts X, and cigarettes, XX% the massive know that there of important VLN, it’s showing studies the XX% in over nicotine to reported adult opportunity data appears adult CBC tobacco billion many we million cigarettes, In risk everyone want market XXXX, and quit in own likely recent which addictive around market global global We year, more that succeed. is vape perception market addictive to of yet alternatives our the and current cigarettes. quit potential VLN. coming XX% than know conventional conventional There year-over-year. years, tobacco nicotine alternatives that world cigarettes. were that XX%, up to Despite actually than seeking rate remind U.S. reduced attempt highly smokers XX% by with less other to are less are those sales of billion for are quit of We our than of with smokers was two more $XXX each to Slide smokers for from modified than the being those to thirds actively of the that use product to encouraged XX smokers to recently smoking conventional
they’ve outcome turned COVID-XX disruption research of the have the shows routines, cigarette leaf Americans regular that another more with struggled tragic and as broader pandemic. smoking of New
X.X on and per has with be non-addictive. addiction. Because This prefer not caused cigarette reduced or cigarette, but the minimally the drastically time death conventional amount that also adult factor smokers, addiction tobacco, cigarette smokes a while alternative is Now to it mg made the sustain FDA are clinical is and and smells studies tobacco; product with disease form being enormous adult designed create based to by gram a nicotine a of like of is to likely an smokers intentionally it just VLN tobacco nicotine cigarette contains said levels. address different by from of a tastes, new amount offering is tobacco
Vanguard tobacco of nicotine ultimate called and researchers to XXXX, XXXX, harm conduct the nicotine indeed around launch the that nicotine, that world reduced cigarettes the of first We XXnd Reducing commercially right. the A independent health. content meaning of in the and the over again, and right the studies believe VLN reduced “the of take authorization Commissioner he over for was in we proposed public on content most cigarettes supplied has to level now the has dozens that The response cigarettes, will reduction can that FDA of strategy. while to of industry, millions Kessler reduction have Kessler positive Century strategy.” craving” reduce near-term our reduce is FDA’s nicotine Dr. FDA VLN our serve Dr. for clinical one mandate. MRTP nicotine scientists a ultimate “if the Since the David harm we reducing and is decisions to application stimulus, of make important said potential as blockbuster shown application
and We authorization. prepared post are VLN MRTP launch fully eager to
offer conventional adult highly addictive alternative to so a And new smokers cigarettes.
to X. Turning Slide
final our final high application MRTP everything At are from no believe requests time, as is, our priority. It Jim of designation there we is our to the number one remains and had required decision about believe a the the mentioned, confidence they securing in for in FDA review outstanding application. with information in make for FDA. this We VLN. stages Our
and consultants, We importance multiple affairs near-term legal to relentlessly and an a advisors, we authorization. will will of through channels with our to MRTP to the will public MRTP never continue application our pursue to for surrender work specialists we designation emphasize continue regulatory and encourage government health VLN.
to now slide X. Turning
launch the We’re fully eager for commercial VLN. of prepared and
program ability on investment, facility projections ample as demand based to X% early manufacture of already growing and tobacco we approximately smokers; operated we planting the VLN This tobacco our increase of in the planting in VLN adult triple the market sales minimal Our to capacity. from for announced our our to crop significant in to inventory. meet cigarette have addition company-owned new year. is manufacturing U.S. VLN volume, January, a and sizeable expansion capacity of in the with XXXX expected and and
cigarette select initial margins expect markets plan market We premium in receiving VLN from the corresponding expected. position with rollout VLN of MRTP the within days XX of segment FDA authorization in of the to and
of number The to campaign awareness. a the will with trade. positively a generate robust launch discussions regional marketing and advanced received VLN in by of independent retailers, continues and currently and brand VLN are be proposition We accompanied by to national tobacco be
product in We maximize rollout a are deploying success approach to to thoughtful the marketplace.
GMO an where to potential as nicotine slide the authorization brand is are designation multiple to that regulatory non-GMO in tobacco as the for and scale plant is tobacco and commercial garner licensing We X. hand, products are world will agencies tobacco to our public to franchise. Let’s preferred a MRTP move products much partnership designation our and or standard in serve markets, catalyst to world. content gold considered build generation the research from around and MRTP we commercializing technology around and the the FDA international expect opportunities non-GMO well Again, in reduced partners, be via our regulators our international. with in business as key plan We health. the by banned. believe U.S. VLN attention next
to progress our continue tobacco We research. significant in make
fourth XXXX, of the we During we successfully varieties quarter to applied bright burly non-GMO and our tobacco. have of technology that confirmed
technology reduced VLN back for content, hemp/cannabis of traits further I’ll now non-GMO introduce varieties X.X, a nicotine next Jim our to into an We of it generation update pass using our development also nicotine our cigarette. tobacco, on are Oriental reduced blend franchise. Jim? American to enabling non-GMO
